Ana Aslan

Overview

Ana Aslan, a pioneering Romanian biologist and physician, dedicated her life to gerontology and geriatrics, revolutionizing the understanding of aging and developing innovative treatments aimed at improving the quality of life for the elderly. Her groundbreaking research and therapeutic interventions earned her international acclaim and established Romania as a leader in geriatric medicine. This timeline highlights key moments in her remarkable life and career.

Main Milestones

Birth in Brăila, Romania

January 1, 1897

Ana Aslan, originally named Anna Aslanyan, was born in Brăila, Romania, to Armenian parents. Even from a young age, she displayed a strong will and a deep compassion, traits that would shape her future dedication to medicine and the well-being of others.

World War I Medical Service

1915-1918

During World War I, while still a medical student, Ana Aslan volunteered as a nurse, providing crucial care to wounded soldiers on the front lines. This experience exposed her to the harsh realities of life and death, solidifying her commitment to medicine and instilling in her a deep sense of empathy for human suffering.

Medical Degree from the University of Bucharest

1922

Ana Aslan successfully completed her medical studies at the University of Bucharest, marking a significant milestone in her journey to becoming a physician. Her academic achievements laid the foundation for her future research and clinical practice in the field of gerontology.

Appointment as Professor at the Institute of Geriatrics in Bucharest

1949

Aslan's dedication to understanding aging and geriatric health led to a professorship at the Institute of Geriatrics in Bucharest, Romania. This opportunity allowed her to establish a strong research foundation and pursue novel treatments. She was instrumental in shaping the field of geriatrics in Romania.

Development of Gerovital H3

1952

Ana Aslan's most significant contribution was the development of Gerovital H3, a procaine-based drug. She argued it had anti-aging effects and was effective in treating various age-related conditions. Gerovital H3 became widely popular, attracting international attention and making Romania a destination for 'rejuvenation' tourism.

Establishment of the National Institute of Geriatrics and Gerontology

1959

Recognizing the growing importance of geriatrics, Ana Aslan founded the world's first National Institute of Geriatrics and Gerontology in Bucharest. This institute became a leading center for research and treatment of age-related diseases, attracting scientists and patients from around the globe.

Development of Aslavital

1974

Building upon her research with Gerovital H3, Aslan developed Aslavital, a similar drug aimed at preventing premature aging. This further solidified her reputation as a pioneer in anti-aging treatments and contributed to the expanding field of geriatric pharmacology.

Death in Bucharest, Romania

May 20, 1988

Ana Aslan passed away in Bucharest, Romania, at the age of 91. Her death marked the end of an era in geriatric medicine. However, her legacy continues to inspire researchers and clinicians dedicated to improving the lives of the elderly. Her contributions remain pivotal in understanding and addressing the challenges of aging.

Other Themed Timelines

Career and Scientific Research Timeline

Early Life and Education Timeline

Gerovital H3 Controversy Timeline

International Recognition and Influence Timeline

Later Life and Death Timeline

Personal Life and Relationships Timeline

Themed Timelines

Talks

Media Collections

Overview

Other Themed Timelines